CLINICAL_TRIALS
trial_result
· 2020-10-05
Clinical Trial Update: Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC) [Phase 2]
Summary
Phase 2 clinical trial update for HX008 in anaplastic thyroid cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taizhou Hanzhong biomedical co. LTD | Conditions: Anaplastic Thyroid Cancer | Phase 2 | Status: UNKNOWN